More than 55 international industry experts and 180 companies are attending CPhI’s Pre-Connect Conference, a global pharmaceutical event coming Oct. 2 in Messe Frankfurt, Germany, to network and discuss industry uncertainties.
Held in conjunction with the CPhI Worldwide Exhibition, a leader for the global pharmaceutical ingredients industry, the 5th Annual Pre-Connect Conference will include industry professionals from many organizations, such as Teva, Merck Serono, Novartis Pharma, Genentech, Ranbaxy, Boehringer Ingelheim, IMS Health, MHRA Biogen, BASF, Sanofi and Bayer.
With expert speakers from the international world of Pharma, the conference offers networking and debates among leaders in the field. Senior pharmaceutical executives will speak on hot topics, such as pressure on revenues due to price controls caused by healthcare reforms and austerity measures, increased competition, and challenges in bringing new drugs and other products to market.
CPhI is also running three free-to-attend In-Focus Sessions across post-conference exhibition days. They will provide hands-on, practical guidance on how to capitalize on the already-established and up-and-coming industry sectors of Biopharmaceuticals, Animal Health and Natural Extracts.
